prazosin and Dyspnea
prazosin has been researched along with Dyspnea in 4 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
Dyspnea: Difficult or labored breathing.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "The cardiocirculatory actions of prazosin (PZN) orally were evaluated by cardiac catheterization, forearm plethysmography, echocardiography, treadmill exercise, and symptoms in patients with advanced long-standing congestive heart failure (CHF)." | 8.76 | Management of refractory congestive heart failure with prazosin. ( Awan, NA; Evenson, MK; Mason, DT; Needham, KE, 1981) |
| "The long-term efficacy of the new oral vasodilator, prazosin (PZ), was evaluated in nine patients with refractory heart failure due to chronic coronary heart disease." | 7.65 | Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodyn ( Awan, NA; DeMaria, AN; Mason, DT; Maxwell, KS; Miller, RR; Neumann, A, 1977) |
| "The cardiocirculatory actions of prazosin (PZN) orally were evaluated by cardiac catheterization, forearm plethysmography, echocardiography, treadmill exercise, and symptoms in patients with advanced long-standing congestive heart failure (CHF)." | 4.76 | Management of refractory congestive heart failure with prazosin. ( Awan, NA; Evenson, MK; Mason, DT; Needham, KE, 1981) |
| "The long-term efficacy of the new oral vasodilator, prazosin (PZ), was evaluated in nine patients with refractory heart failure due to chronic coronary heart disease." | 3.65 | Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodyn ( Awan, NA; DeMaria, AN; Mason, DT; Maxwell, KS; Miller, RR; Neumann, A, 1977) |
Research
Studies (4)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Awan, NA | 2 |
| Evenson, MK | 1 |
| Needham, KE | 1 |
| Mason, DT | 2 |
| Sterz, H | 1 |
| Bertel, O | 1 |
| Miller, RR | 1 |
| DeMaria, AN | 1 |
| Maxwell, KS | 1 |
| Neumann, A | 1 |
Reviews
1 review available for prazosin and Dyspnea
| Article | Year |
|---|---|
Management of refractory congestive heart failure with prazosin.
Topics: Animals; Drug Evaluation; Drug Tolerance; Dyspnea; Echocardiography; Fatigue; Heart Failure; Hemodyn | 1981 |
Other Studies
3 other studies available for prazosin and Dyspnea
| Article | Year |
|---|---|
[Causes of acute valve-conditioned left ventricular insufficiency-- attempt at a tabulated review].
Topics: Aortic Valve Insufficiency; Cardiac Glycosides; Dyspnea; Endocarditis, Bacterial; Humans; Hydralazin | 1984 |
Long-term therapy with prazosin in severe chronic congestive heart failure.
Topics: Blood Pressure; Capillary Resistance; Dyspnea; Heart Failure; Heart Rate; Humans; Prazosin; Quinazol | 1980 |
Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodyn
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Blood Pressure; Cardiac Output; Chronic Disease; | 1977 |